Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a Cancer Stem Cell (CSC) antibody discovery program focused on therapies for acute myeloid leukemia, multiple myeloma and myelodysplastic syndrome.
View Top Employees from Cellerant TherapeuticsWebsite | https://www.cellerant.com |
Revenue | $4 million |
Funding | $102.9 million |
Employees | 26 (12 on RocketReach) |
Founded | 2003 |
Address | 1561 Industrial Rd, San Carlos, California 94070, US |
Phone | (650) 232-2122 |
Fax | (650) 232-5495 |
Technologies |
G Suite,
Gmail,
GoDaddy DNS
+7 more
(view full list)
|
Industry | Biotechnology, Business Services, Stem Cells, Science and Engineering, Neutropenia, Clinical Trials, Oncology, Health Care, Thrombocytopenia, Therapeutics |
Web Rank | 14 Million |
Keywords | Cellerent, Jagath Reddy Junutula Email Address, Cellerant Therapeutics, Pipeline Cellerant Therapeutics |
Competitors | Assembly Biosciences, Inc., Capricor Therapeutics, Inc., GlycoMimetics, Kadimastem Ltd., OxThera |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular Cellerant Therapeutics employee's phone or email?
The Cellerant Therapeutics annual revenue was $4 million in 2024.
Rod Van Syoc is the Senior Director, Clinical Operations of Cellerant Therapeutics.
12 people are employed at Cellerant Therapeutics.
Cellerant Therapeutics is based in San Carlos, California.
The NAICS codes for Cellerant Therapeutics are [54171, 541, 5417, 54, 541714].
The SIC codes for Cellerant Therapeutics are [87, 873].